Analysis of the clinicopathological characteristics and prognosis of triple-positive breast cancer and HER2-positive breast cancer—A retrospective study

BACKGROUND: Adjuvant chemotherapy and targeted therapy have become standard postoperative therapeutic modalities for human epidermal growth factor receptor 2 (HER2)-positive breast cancer(HER2-positive,HR-negative), including triple-positive breast cancer(HER2-positive,HR-positive). However, these t...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Dongxu, Yang, Qing, Yin, Ke, Shi, Peng, Chen, Xiao, Dong, Tianyi, Shang, Xingchen, Tian, Xingsong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9885258/
https://www.ncbi.nlm.nih.gov/pubmed/36727058
http://dx.doi.org/10.3389/fonc.2022.999894

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9885258/
https://www.ncbi.nlm.nih.gov/pubmed/36727058
http://dx.doi.org/10.3389/fonc.2022.999894

Ejemplares similares